Cameron et al.1 report on a pilot of early medical abortion in a group of women with pregnancies less than 8 weeks. They demonstrated good patient experiences and high levels of satisfaction in this group of women; in the immediate aftermath of the abortion. I do, however, have serious concerns regarding their administration of mifepristone right away, on the same day, following patient assessm...

We write in support of using mifepristone at the fi rst visit for early medical abortion (EMA), without an obligatory cooling-off period.1 In our service in South East Wales, we have been providing home EMA since 2007 in a setting very similar to that described in the pilot study reported by Cameron et al.2 Similarly, patients attending our service are able to have mifepristone administered at ...

No method of contraception is 100% effective; over half the women seeking an abortion are using contraception (Jones et al., 2002). It has been estimated that 42 million abortions are carried out every year, and half of these are illegal and unsafe (Sedgh et al., 2007). A proportion of women of all backgrounds with an unintended pregnancy are going to seek an abortion, legal or illegal, irrespe...

While the medical abortion (MA) drugs, mifepristone and misoprostol, have radically altered reproductive health practices around the world, there has been little field research on the sales and use of these drugs, especially in developing countries. This leaves the family planning community with many unanswered questions. While good profiles of contraceptive use are available for many countries...

INTRODUCTION Little is known about Australian rural women's overall experiences of accessing an abortion service and the barriers they encounter. Approximately one in three Australian women access an abortion at some time in their lives. Most abortions are undertaken during the first trimester of pregnancy in private clinics. Although both medical and surgical abortions are uncomplicated medica...